Subscribe To
Zyversa therapeutics adds dr. douglas golenbock to its inflammatory disease scientific advisory board to support advancement of inflammasome asc inhibitor ic 100
Dr. Golenbock is The Neil and Margery Blacklow Chair in Infectious Diseases and Immunology and Professor and Chief, Division of Infectious Diseases an...
April 24, 2023, 1:07 pm
Ideaya biosciences shares jump on melanoma interim trial results
IDEAYA Biosciences shares jumped after the company posted additional positive interim results from its Phase 2 clinical trial evaluating its darovaser...
April 24, 2023, 12:27 pm
Inhibikase therapeutics to present at the 2023 planet microcap showcase
BOSTON and ATLANTA , April 21, 2023 /PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ("Inhibikase" or "Company"), a clinical-stage pharmace...
April 21, 2023, 8:30 am
Cinemark to host first quarter 2023 earnings conference call
PLANO, Texas--(BUSINESS WIRE)--Cinemark Holdings, Inc. (“Cinemark”) (NYSE: CNK), one of the largest motion picture exhi...
April 20, 2023, 4:45 pm
Anti-vegf market to cross us$ 34.9 billion revenues between 2023 and 2033 – persistence market research
Increasing Government Investments in Development of Efficient Healthcare Systems Aiding Demand Growth for VEGF Inhi...
April 18, 2023, 12:42 pm
Sap sapphire & asug annual conference 2023: xsuite to present latest additions to their sap product portfolio
AHRENSBURG, Germany & FRAMINGHAM, Mass.--(BUSINESS WIRE)-- #ILM--The SAP Sapphire & ASUG Annual Conference Orlando will be held on 16 and 17 May 2023 ...
April 18, 2023, 8:46 am
Tesla faces a tougher road ahead in china
The company hasn't said why it won't join the more than 100 exhibitors packing China's most prestigious...
April 18, 2023, 2:06 am
Frontier medicines presents new preclinical data on its development candidate, fmc-376, a dual krasg12c inhibitor, at the 2023 aacr annual meeting
-FMC-376 is a highly selective, direct dual inhibitor designed to rapidly and completely block both the...
April 16, 2023, 7:00 pm
Quanta therapeutics presents data from kras inhibitor pipeline at annual aacr meeting in late-breaking research session
– Data highlight favorable preclinical profiles for two chemically-distinct allosteric, oral small molecule KRAS inhi...
April 14, 2023, 4:05 pm
Ardelyx presents positive data further supporting efficacy and safety of xphozah® (tenapanor) at national kidney foundation 2023 spring clinical meetings
Three posters support the important role that XPHOZAH, a novel phosphate absorption inhibitor, could po...
April 12, 2023, 8:05 pm
Kalvista pharmaceuticals to present at 22nd annual needham virtual healthcare conference
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)---- $KALV--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical compa...
April 12, 2023, 6:30 am
Foghorn therapeutics to present preclinical data from its selective cbp and ep300 protein degrader programs and preclinical data for fhd-286, a potent, selective inhibitor of brg1 and brm, at the 2023
CAMBRIDGE, Mass., April 10, 2023 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a n...
April 10, 2023, 4:05 pm
Aptose to participate in canaccord genuity's 2023 horizons in oncology virtual conference
SAN DIEGO and TORONTO, April 10, 2023 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a cli...
April 10, 2023, 4:01 pm
Aadi bioscience to present multiple posters at the american association for cancer research (aacr) annual meeting 2023
LOS ANGELES , April 6, 2023 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing a...
April 6, 2023, 4:35 pm
Judge denies quick settlement of amc entertainment shareholder lawsuit
The judge in a case brought by meme stock shareholders against AMC Entertainment declined to approve a settlement unveiled earlier this week that woul...
April 6, 2023, 9:12 am
Disc medicine reports full year 2022 financial results and provides business update
Completed reverse merger with Gemini Therapeutics, debuting on Nasdaq as “IRON” and ending 2022 with approximately $194.6 million in cash and cash...
March 31, 2023, 11:00 am
Etf of the week: proshares bitcoin strategy etf (bito)
VettaFi's vice chairman Tom Lydon discussed the ProShares Bitcoin Strategy ETF (bito) on this week's �...
March 30, 2023, 5:58 pm
Effector therapeutics to participate in upcoming investor conferences
SOLANA BEACH, Calif. and REDWOOD CITY, Calif., March 28, 2023 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the developm...
March 28, 2023, 8:30 am
Verona's ensifentrine: a promising novel treatment for copd patients
Verona Pharma's ensifentrine is a first-in-class, inhaled, dual inhibitor of the enzymes PDE3 and PDE4,...
March 27, 2023, 2:31 am
Aptose biosciences announces q4 and fy 2022 results
Aptose Biosciences (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral kinase inhi...
March 24, 2023, 2:20 pm